Trial intelligence / Profile preview

Nandrolone for prolonged mechanical ventilation weaning in poisoned ICU patients

IRCT20091116002717N3Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in respiratory failure and Intoxication comparing Nandrolone plus routine care with Placebo plus routine care (2 arms). Primary endpoints: Duration of intubation, Rapid shallow breathing index and 4 more. Started May 2025; status: completed.

02

Drugs

nandrolone
03

Conditions

respiratory failureIntoxication

Beyond the preview

Go deeper on IRCT20091116002717N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20091116002717N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call